Online inquiry

IVTScrip™ mRNA-Human ADSSL1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK7773MR)

This product GTTS-WK7773MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ADSSL1 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001320424.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 122622
UniProt ID Q8N142
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADSSL1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK7773MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14350MR IVTScrip™ mRNA-Human ADH7, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADH7
GTTS-WK2626MR IVTScrip™ mRNA-Human CD73, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CD73
GTTS-WK16924MR IVTScrip™ mRNA-Human ALKBH3, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ALKBH3
GTTS-WK7030MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK20182MR IVTScrip™ mRNA-Human AKT3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AKT3
GTTS-WK19342MR IVTScrip™ mRNA-Human ALPPL2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ALPPL2
GTTS-WK18308MR IVTScrip™ mRNA-Human AGPAT1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AGPAT1
GTTS-WK0017MR IVTScrip™ mRNA-Human PHEX, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA PHEX
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →